1. Aims and Scope CHROMATOGRAPHY is a journal published by the Society of Chromatographic Science (SCS). It is an international, open-access scientific journal dedicated to the publication of high-quality original research, reviews, and technical reports in the field of separation and detection science and related disciplines, including chromatography, electrophoresis, and related methodologies.
The journal aims to disseminate significant experimental and theoretical advances that contribute to the development and application of separation and detection methodologies. 2. Editorial Responsibility
The Editor-in-Chief has overall responsibility for the editorial content and policies of CHROMATOGRAPHY. Editorial decisions are supported by Associate Editors and the Editorial Board, who oversee the peer-review process and ensure that manuscripts are evaluated fairly, objectively, and confidentially. Editorial decisions are based solely on the scientific merit of the manuscript. Editorial decisions are made independently of any commercial, financial, or advertising considerations. 3. Peer-review Process
All submitted manuscripts undergo an initial editorial screening to assess their suitability for CHROMATOGRAPHY. Manuscripts that pass this screening are subjected to peer review by independent experts in the relevant field. CHROMATOGRAPHY employs a single-blind peer-review process, unless otherwise stated.
The editorial office aims to reach a decision within a reasonable time frame, typically within two rounds of peer review. Additional rounds of review are conducted only when scientifically or procedurally necessary. 4. Criteria for Acceptance
Manuscripts are evaluated based on originality, scientific quality, methodological soundness, clarity of presentation, and relevance to the scope of CHROMATOGRAPHY. Submissions must present novel findings or significant advances in separation and detection science. Redundant or incremental studies lacking sufficient novelty will not be considered for publication. 5. Publication Ethics and COPE Compliance CHROMATOGRAPHY adheres to internationally accepted standards of publication ethics and follows the principles and best practices set out by the Committee on Publication Ethics (COPE). Authors must ensure that their work is original, has not been published previously, and is not under consideration for publication elsewhere. Plagiarism, data fabrication, data falsification, citation manipulation, and inappropriate image manipulation are strictly prohibited.
Editors, reviewers, and authors are expected to adhere to COPE guidelines in all aspects of the publication process, including but not limited to authorship, conflicts of interest, peer-review integrity, and the handling of ethical concerns. Allegations of misconduct will be investigated in accordance with COPE flowcharts and recommendations to ensure fair, transparent, and consistent resolution.
All manuscripts are screened for plagiarism prior to peer review through editorial assessment and similarity-detection methods. 6. Role of the Funding Source
Authors are required to disclose all sources of financial support for the conduct of the research and/or the preparation of the manuscript. Authors must also describe the role of the funding source(s), if any, in study design; data collection, analysis, and interpretation; manuscript preparation; and the decision to submit the article for publication.
If the funding source(s) had no involvement in any of these aspects, authors must explicitly state this in the manuscript. 7. Ethical Standards for Experiments with Human Beings and Animals
Authors are responsible for clearly identifying any chemicals, procedures, or equipment with inherent hazards in their manuscripts. When research involves human participants or animals, authors must ensure compliance with all relevant laws, regulations, and institutional guidelines, including approval by appropriate institutional review boards or ethics committees.
For studies involving human subjects, authors must include a statement confirming that informed consent was obtained. The privacy rights of human subjects must always be respected. Human research should be conducted in accordance with the World Medical Association's Declaration of Helsinki.
Animal experiments must comply with the ARRIVE guidelines and applicable legislation, such as the U.K. Animals (Scientific Procedures) Act 1986 or EU Directive 2010/63/EU.
The Editor-in-Chief reserves the right to reject manuscripts that fail to meet these ethical standards. Written consent must be obtained for the publication of case details or personal information, and evidence of such consent must be provided upon request.
8. Authorship and Contributions
Authorship should be limited to individuals who have made substantial contributions to the conception, design, execution, or interpretation of the reported study. All authors must approve the final version of the manuscript and agree to its submission. Any changes to authorship after submission must be approved by all listed authors and justified to the editorial office.
Authors must describe individual contributions using the Contributor Roles Taxonomy (CRediT). Not all roles may apply to every manuscript, and individual authors may have contributed in more than one role.
The designated corresponding author serves as the primary point of contact throughout the review and publication process and should not be changed without prior approval from the editorial office. 9. Changes to Authorship
Authors are expected to carefully consider the list and order of authors before submitting their manuscript and to provide the definitive list of authors at the time of the original submission. Any addition, deletion, or rearrangement of author names should be made only before the manuscript has been accepted and only with the approval of the journal Editor.
To request a change in authorship, the corresponding author must submit the following to the Editor:
(a) the reason for the proposed change to the authorship list; and
(b) written confirmation (e-mail or letter) from all listed authors confirming their agreement with the addition, removal, or rearrangement of authors.
In cases involving the addition or removal of authors, confirmation must also be obtained from the author being added or removed.
Only in exceptional circumstances will the Editor consider requests for changes to authorship after the manuscript has been accepted. While such a request is under consideration, publication of the manuscript will be suspended. If the manuscript has already been published online, any approved changes will be implemented through the publication of a corrigendum. 10. Conflicts of Interest
All authors are required to disclose any financial or non-financial conflicts of interest that could be perceived to influence the results or interpretation of their work. Reviewers and editors must also declare potential conflicts and recuse themselves from handling manuscripts when appropriate. 11. Open Access Policy
All articles published in CHROMATOGRAPHY are open access and freely available to readers immediately upon publication. Articles are published under either the Creative Commons Attribution (CC BY) 4.0 International License or the Creative Commons Attribution-NonCommercial (CC BY-NC) 4.0 International License, as selected by the authors after manuscript acceptance. For articles published under the CC BY-NC 4.0 International License, commercial use is not permitted without prior permission from the copyright holder. Articles published under the CC BY 4.0 International License may be reused for commercial and non-commercial purposes in accordance with the terms of that license.
For articles submitted on or after [effective date], authors retain copyright of their work. Articles published prior to this date remain subject to the copyright policy in effect at the time of publication. The choice of license does not influence editorial decisions. 12. Copyright and Licensing
Authors retain copyright of their work and grant CHROMATOGRAPHY a non-exclusive right to publish the article. Articles are made available under the selected Creative Commons license in accordance with the journal's open-access policy. Requests for commercial use must be directed to the copyright holder. If the copyright holder cannot be contacted using the information provided in the article, inquiries may be directed to the Editorial Office. Where possible, the Editorial Office will attempt to facilitate communication with the author(s), but cannot grant permissions on behalf of the copyright holder. 13. Appeals and Complaints
Authors may appeal editorial decisions by submitting a written request to the Editorial Office, clearly stating the grounds for appeal. Appeals are reviewed in accordance with established editorial procedures. Complaints regarding editorial processes or ethical concerns are handled transparently and in line with COPE guidelines. 14. Corrections and Retractions
The journal is committed to maintaining the integrity of the scientific record. Corrections, retractions, or expressions of concern will be issued when necessary to address errors, misconduct, or ethical issues identified after publication. 15. Language and Editorial Quality
Manuscripts must be written in clear, grammatically correct English. Authors are encouraged to seek professional language editing if necessary prior to submission. The editorial office reserves the right to make minor stylistic or formatting changes to improve clarity and consistency. 16. Disclaimer
The views expressed in published articles are those of the authors and do not necessarily reflect those of the editors, editorial board, or publisher. 17. Use of Artificial Intelligence (AI) Tools
The use of artificial intelligence (AI)-based tools is permitted only to support manuscript preparation and related activities. AI tools must not replace the critical intellectual contributions or scientific responsibilities of the authors.
Authors are responsible for the accuracy, originality, and integrity of all content in their manuscripts, including any material produced with the assistance of AI tools.
The use of AI tools must be transparently disclosed in the manuscript. AI tools cannot be listed as authors under any circumstances.
18. Data Availability and Sharing Policy CHROMATOGRAPHY encourages authors, whenever possible, to make the data underlying their published research publicly available in order to promote transparency, reproducibility, and the reuse of scientific results. Authors must include a Data Availability Statement that describes where and how the supporting data can be accessed or explains any restrictions on data access.
When applicable, authors are encouraged to deposit supporting data in recognized public repositories prior to publication. If data cannot be shared due to ethical, legal, or confidentiality constraints, this must be clearly stated in the manuscript.
19. Advertising and Direct Marketing CHROMATOGRAPHY adheres to a clear and transparent advertising policy. The journal defines the types of advertisements that may be considered for publication and the procedures by which advertising content is reviewed and approved.
All advertising and direct marketing activities are entirely independent of editorial decision-making. The acceptance, placement, or content of advertisements shall not influence editorial decisions, peer-review processes, or the content of published articles. Advertising materials are clearly distinguished from editorial content to avoid any potential conflict of interest.
(Last updated: Jun. 10, 2026)
